Aminoglycoside-Modifying Enzymes Are Sufficient to Make <i>Pseudomonas aeruginosa</i> Clinically Resistant to Key Antibiotics
Aminoglycosides are widely used to treat infections of <i>Pseudomonas aeruginosa</i>. Genes encoding aminoglycoside-modifying enzymes (AMEs), acquired by horizontal gene transfer, are commonly associated with aminoglycoside resistance, but their effects have not been quantified. The aim...
Saved in:
Main Authors: | Aswin Thacharodi (Author), Iain L. Lamont (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gene-Gene Interactions Reduce Aminoglycoside Susceptibility of <i>Pseudomonas aeruginosa</i> through Efflux Pump-Dependent and -Independent Mechanisms
by: Aswin Thacharodi, et al.
Published: (2023) -
Artemisinin derivative DHA27 enhances the antibacterial effect of aminoglycosides against Pseudomonas aeruginosa by inhibiting mRNA expression of aminoglycoside-modifying enzymes
by: Nuoyan Wang, et al.
Published: (2022) -
The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant <i>Pseudomonas aeruginosa</i> Infections
by: Aisling R. Caffrey, et al.
Published: (2022) -
Characteristics of Antibiotic Resistance and Tolerance of Environmentally Endemic <i>Pseudomonas aeruginosa</i>
by: Seryoung Kim, et al.
Published: (2022) -
Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Clinical Strains: A Challenge for Tertiary Care Hospitals
by: Aamir Jamal Gondal, et al.
Published: (2024)